Advice
Indication withdrawn
The marketing authorisation for collagense clostridum histolyticum (Xiapex) has been withdrawn – see link
Medicine details
- Medicine name:
- collagenase (Xiapex)
- SMC ID:
- 715/11
- Indication:
treatment of Dupuytren' s contracture in adult patients with a palpable cord.
- Pharmaceutical company
- Pfizer Ltd
- BNF chapter
- Musculoskeletal and joint diseases
- Submission type
- Resubmission
- Status
- Withdrawn
- Date advice published
- 14 May 2012
Additional notes
The marketing authorisation for collagense clostridum histolyticum (Xiapex) has been withdrawn – see link